Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

Global biopharmaceuticals company <keyword id="6358361" type="General" weightage="100" keywordseo="biocon" source="Orion">Biocon</keyword> on Wednesday reported 23 per cent rise in revenue for the first quarter of financial year 2023, at Rs 2,217 crore. "We have had a strong start to the year. At a consolidated level, YoY revenues grew 23 per cent backed by robust growth in both <keyword id="6359687" type="General" weightage="50" keywordseo="biosimilars" source="Orion">Biosimilars</keyword> (29 per cent) and Generics (19 per cent). Core earnings before interest, taxes, depreciation, and amortisation (EBITDA) grew 25 per cent and margin improved to 31 per cent compared to 30 per cent in Q1FY22 and net profit grew 71 per cent to Rs 144 crore. "Our financial performance this quarter includes the impact of annual increments in personnel costs as well as increased input and freight costs, pursuant to pandemic and geopolitical disruptions of global supply chains. "All our three businesses are poised for the next phase of strong and sustainable growth which has been challenged during the two years of the Covid-19 pandemic," <keyword id="14575168" type="General" weightage="50" keywordseo="biocon-and-biocon-biologics-executive" source="Orion">Biocon and Biocon Biologics Executive</keyword> <keyword id="10034873" type="General" weightage="20" keywordseo="chairperson-kiran-mazumdar-shaw" source="Orion">Chairperson Kiran Mazumdar-Shaw</keyword> said. Sales of Glargine in the US, and key biosimilars in emerging markets were the main drivers for <keyword id="14245336" type="General" weightage="50" keywordseo="biocon-biologicals" source="Orion">Biocon Biologicals</keyword>' strong performance. <keyword id="10493627" type="General" weightage="50" keywordseo="biocon-biologics-ltd" source="Orion">Biocon Biologics Ltd</keyword> Managing Director <keyword id="287851" type="General" weightage="50" keywordseo="arun-chandavarkar" source="Orion">Arun Chandavarkar</keyword> said: "Initiation of global clinical trials for two monoclonal antibodies and advancement of our other pipeline assets led to a 120 per cent increase in our research and development investments this quarter. Whilst this impacts EBITDA in the near term, such investments will create a strong portfolio to secure our future growth. "Our strategic alliance with Serum Institute Life Sciences for vaccines and the acquisition of Viatris' global biosimilars business are on track for closure in the second half of this calendar year." SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/india/news/reduction-in-rice-cereals-sown-area-worrisome-bank-of-baroda/articleshow/93175801.cms">Reduction in rice, cereals sown area worrisome: Bank of Baroda</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/tech/news/oppo-pad-air-review-sleek-and-stylish-but-short-on-power/articleshow/93165775.cms">Oppo Pad Air review: Sleek and stylish but short on power</a>

Biocon Q1FY23 revenue up 23% at Rs 2,217 cr

<ul><li>The 30-share BSE index was trading 334 points higher, and the broader NSE <keyword id="6354813" type="UNKNOWN" weightage="20" keywordseo="Nifty">Nifty</keyword> was trading 0.75% higher on Tuesday at 9:50 am. </li><li>Here's a list of the top losers and gainers in the Nifty pack. </li><li>These are the <keyword id="35164" type="PERSON" weightage="20" keywordseo="top-stocks">top stocks</keyword> that are buzzing in trade today.</li><li><a href="https://www.businessinsider.in/">Check out the latest news and updates on Business Insider.</a> </li></ul>Indian equity benchmark indices hit record higher in early trade on Tuesday, tracking positive cues from their global peers. The 30-share BSE index was trading 334 points higher, and the broader NSE Nifty was trading 0.75% higher on Tuesday at 9:50 am. Here’s a list of the top losers and gainers in the Nifty pack. <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Top Nifty Gainers </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Top Nifty Losers </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Adani Ports </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">RIL </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Maruti </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Bajaj Finance </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Eicher Motors </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">JSW Steel </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">M&amp;M </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">HDFC Life </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Tata Motors </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">UltraTech Cement </td></tr></tbody></table>*as of November 24, 9:50 am These are the top stocks in news today. Axis Bank soars on bullish analyst recommendation Axis Bank shares soared over 2% after Jefferies maintained a 'buy' call on the stock and has raised its target to ₹700 per share from ₹610 earlier. Future Retail hits 10% upper circuit for the second day in a row The shares of Future Retail were locked in a 10% upper circuit for the second day in a row after the CCI approved the Reliance deal to buyout Future Group's retail assets. SpiceJet gains 3% The shares of SpiceJet soared 3% after its subsidiary SpiceHealth launched a budget Covid test. The company said it would conduct the Real-Time Polymerase Chain Reaction (RT-PCR) test for COVID-19 starting at ₹499, which will drastically reduce the price of the RT-PCR test, which ordinally costs ₹3500. <keyword id="719816" type="DOMAIN" weightage="20" keywordseo="Jubilant-Industries">Jubilant Industries</keyword> soars 7% The shares of Jubilant Industries soared 7% after it decided to transfer its liquor license. The company said it would not manufacture India Made Foreign Liquor hereon. <keyword id="357699" type="COMPANY" weightage="20" keywordseo="Ingersoll-Rand-India">Ingersoll Rand India</keyword> slumps 6% The shares of Ingersoll Rand India slumped 6% in early trading hours on Tuesday after its promoter Ingersoll Rand Inc said it would sell up to 4.52% stake through an Offer for Sale (OFS) at a floor price of ₹578.6/share. The offer opens for non-retail investors today and tomorrow for retail investors. <keyword id="6358361" type="COMPANY" weightage="20" keywordseo="biocon">Biocon</keyword> trades over a percent higher The shares of Biocon gained over a percent after it entered into an agreement for the acquisition of a 26% equity stake on a fully diluted basis in Hinduja Renewables Two (HRTPL), a special purpose vehicle formed for the purpose of power generation and developing a captive power plant as per Electricity laws. GHCL gained nearly 2% The shares of GHCLgained nearly 2% after the stock exchanges have given a no-objection letter for the demerger of the company's textile business into GHCL Textiles. SEE ALSO: <a href="https://www.businessinsider.in/politics/world/news/biden-will-pick-former-federal-reserve-chair-janet-yellen-to-head-the-treasury-department/articleshow/79378968.cms" data-type="tilCustomLink">Biden will pick former Federal Reserve Chair Janet Yellen to head the Treasury Department</a> <a href="https://www.businessinsider.in/politics/world/news/boris-johnson-to-relax-the-national-coronavirus-lockdown-and-allow-households-to-celebrate-together-over-christmas/articleshow/79368293.cms" data-type="tilCustomLink">Boris Johnson relaxes the national coronavirus lockdown and says families can meet to celebrate Christmas</a>

Market at record high, Nifty hits 13,000 — Here are the top stock movers in trade today

If you think <keyword id="10387" type="CITY" weightage="60" keywordseo="Microsoft">Microsoft</keyword>’s prolonged search for the next <keyword id="5645" type="POSITION" weightage="100" keywordseo="CEO">CEO</keyword> is getting a bit nutty, especially with a disgruntled <keyword id="62333" type="PERSON" weightage="60" keywordseo="Steve-Ballmer">Steve Ballmer</keyword> waiting on the sidelines to hand over the mantle, you are not far from the truth. But then, that is the actual state of the coveted C-Suite nowadays – volatile is the right word if you want to sum it up. There is no job security at the top and even the best performer for years can get redundant within the span of a few weeks. The issues could be many – right from <keyword id="646347" type="UNKNOWN" weightage="100" keywordseo="poor-performance">poor performance</keyword> to <keyword id="610960" type="UNKNOWN" weightage="100" keywordseo="business-restructuring">business restructuring</keyword> to alleged <keyword id="6375736" type="UNKNOWN" weightage="100" keywordseo="corruption-charges">corruption charges</keyword>. But the biggest factor is relevance, a perfect future-fit that can take companies ahead, according to <keyword id="67736" type="UNKNOWN" weightage="100" keywordseo="Industry-experts">industry experts</keyword>. In a difficult <keyword id="34412" type="ORGANIZATION" weightage="100" keywordseo="economy">economy</keyword>, companies are compelled to twist and turn to keep track of profitability and their requirements change accordingly. Hence, their leaders have to adapt, shape up or ship out, as the case might be. 
 India is no exception and business leaders across the country have been frequently ‘released’ by industry giants. Many of them leave with ‘immediate effect’ while others are on garden leave or worse still, waiting for their predecessors to turn up (just like Ballmer). Yet, most of the C-Suite executives are tight-lipped about their departures, at least here in India. We are yet to come across an announcement like the one made by <keyword id="384914" type="PERSON" weightage="60" keywordseo="Groupon">Groupon</keyword>’s founder and former CEO <keyword id="488139" type="PERSON" weightage="60" keywordseo="Andrew-Mason">Andrew Mason</keyword>. But exit happens all the same – be it discreet or blatant. Here’s a quick look at some of the top-notch C-Suite executives from India who parted ways with their respective companies in 2013, their official exit lines and what happened behind the scene.

Strife At The Top: These
11 C-Suite Execs From India
Were ‘Let Go’ In 2013

<ul><li>Help has been pouring in for <keyword id="6355101" type="General" weightage="100" keywordseo="ukraine" source="Orion">Ukraine</keyword> from several corners, apart from the full weight of the Western nations behind the country. </li><li>After appeals by the country’s politicians, including its prime minister <keyword id="9393544" type="General" weightage="20" keywordseo="volodymyr-zelenskyy" source="Orion">Volodymyr Zelenskyy</keyword>, Big Tech has stepped up its efforts to fight back against Russian aggression. </li><li>Here’s a look at how big tech companies, including <keyword id="6354427" type="General" weightage="20" keywordseo="Apple" source="Orion">Apple</keyword>, <keyword id="6355629" type="General" weightage="20" keywordseo="Google" source="Orion">Google</keyword>, SpaceX, Microsoft and others have helped Ukraine to fight back against <keyword id="6358826" type="General" weightage="80" keywordseo="russia" source="Orion">Russia</keyword>. </li></ul>The ongoing Russia-Ukraine war has seen the Western world take a decisive stance against Russia, and it’s not just the governments that are trying to help Ukraine – Big Tech has stepped up in its bid to not only offer assistance to Ukraine but also actively take a stance against Russian aggression. Ukrainian politicians, right from the country’s prime minister Volodymyr Zelenskyy to ordinary citizens, have been trying to defy Russian aggression in various capacities. Zelenskyy’s appeals have also managed to move foreign nationals enough for them to enter Ukraine to fight back against Russian forces. However, apart from Western nations, Big Tech has also played a significant role in making things difficult for Russia, and easier for Ukraine. <cmsannotation type="cmsannotation" annotationid="Here’s how Big Tech is trying to aid Ukraine and fight back against Russia" comment="subhead" text="Here’s how Big Tech is trying to aid Ukraine and fight back against Russia">Here’s how Big Tech is trying to aid Ukraine and fight back against Russia</cmsannotation> <cmsannotation type="cmsannotation" annotationid="Elon Musk’s SpaceX brings Starlink constellation over Ukraine" comment="subhead" text="Elon Musk’s SpaceX brings Starlink constellation over Ukraine"><keyword id="6355315" type="General" weightage="20" keywordseo="Elon-Musk" source="Orion">Elon Musk</keyword>’s SpaceX brings <keyword id="7612156" type="General" weightage="20" keywordseo="starlink" source="Orion">Starlink</keyword> constellation over Ukraine</cmsannotation> Elon Musk responded to a request on <keyword id="6354616" type="General" weightage="20" keywordseo="Twitter" source="Orion">Twitter</keyword>, helping Ukrainian residents access the internet once again. The SpaceX boss aligned the Starlink satellite constellation to beam internet over Ukraine, helping the country recover from the Russian forces’ onslaught on Ukraine’s communications infrastructure. <cmsannotation type="cmsannotation" annotationid="Apple stops all sales in Russia" comment="subhead" text="Apple stops all sales in Russia">Apple stops all sales in Russia</cmsannotation> In its first step, Apple announced that it is stopping all sales in Russia after appeals from Ukraine’s deputy prime minister. Apart from this, it also stopped traffic and live incident updates in Apple Maps, and blocked access to the App Store in Russia. Outside of Russia, Apple said it removed RT and <keyword id="541062" type="General" weightage="20" keywordseo="sputnik" source="Orion">Sputnik</keyword> apps from the App Store in a bid to help curtail Russian propaganda. <cmsannotation type="cmsannotation" annotationid="Microsoft keeping a check on Russian hacking threats" comment="subhead" text="Microsoft keeping a check on Russian hacking threats">Microsoft keeping a check on Russian hacking threats</cmsannotation> On its part, Microsoft said it is trying to detect and alert the Ukrainian government about cyber attacks against the country, targeting Ukraine’s digital assets, finance, agriculture and other critical sectors. Apart from this, it also removed the RT app from the Windows App Store and deranked RT and Sputnik on Bing. <cmsannotation type="cmsannotation" annotationid="Meta, Twitter and YouTube help mitigate Russian disinformation campaigns" comment="subhead" text="Meta, Twitter and YouTube help mitigate Russian disinformation campaigns">Meta, Twitter and YouTube help mitigate Russian disinformation campaigns</cmsannotation> Facebook, Twitter and YouTube have all placed restrictions on Russian state-media from running ads on their platforms, with YouTube going a step further and demonetising these media publications. Apart from this, these platforms are also working to fact check Russian disinformation campaigns. <cmsannotation type="cmsannotation" annotationid="Google disables live traffic data in Ukraine" comment="subhead" text="Google disables live traffic data in Ukraine">Google disables live traffic data in Ukraine</cmsannotation> The search giant announced that it has updated its Search and Maps services to help refugees get the latest information from United Nations resources. It also disabled live traffic and busy-ness layers from Google Maps in a bid to keep the local population safe. Additionally, Google also revealed that it is trying to help Ukrainian websites stay up by staving off Distributed Denial of Service (DDoS) attacks from Russia. It also blocked RT and Sputnik channels on YouTube. <cmsannotation type="cmsannotation" annotationid="Netflix denies the addition of Russian state channels on its platform" comment="subhead" text="Netflix denies the addition of Russian state channels on its platform"><keyword id="128682" type="General" weightage="20" keywordseo="Netflix" source="Orion">Netflix</keyword> denies the addition of Russian state channels on its platform</cmsannotation> Netflix defied Russian laws to add 20 Russian state channels on its platform. It was required to do so because of a law that came into force on March 1. Media reports also suggest that Netflix has also paused all Russian programme productions and new acquisitions. CD Projekt Red stops sale of its video game Cyberpunk 2077 in Russia and Belarus Popular video game developer CD Projekt Red, based out of neighbouring Poland, <a href="https://www.businessinsider.in/tech/news/cyberpunk-2077-video-game-developer-halts-all-sales-to-russia-and-belarus/articleshow/89984261.cms">announced</a> that it has stopped sales of its video game, Cyberpunk 2077, in Russia and Belarus. This includes sales via its digital as well as physical distribution networks. SEE ALSO: <a href="https://www.businessinsider.in/tech/news/cyberpunk-2077-video-game-developer-halts-all-sales-to-russia-and-belarus/articleshow/89984261.cms">Cyberpunk 2077 video game developer halts all sales to Russia and Belarus</a> <a href="https://www.businessinsider.in/stock-market/news/maruti-suzuki-biocon-asian-paints-indigo-among-10-worst-stocks-that-made-investors-poorer-this-week/articleshow/89987956.cms">Maruti Suzuki, Biocon, Asian Paints, Indigo among 10 worst stocks that made investors poorer this week</a> <a href="https://www.businessinsider.in/business/telecom/news/vodafone-idea-news-board-approves-14500-crore-fundraising-plan/articleshow/89983243.cms">Even a big fundraise is not helping Vodafone investors as Russia-Ukraine conflict takes the wind out of global markets</a>

From SpaceX to Apple, Google and Twitter – here’s how Big Tech is trying to help Ukraine against Russia

<ul><li>The <keyword id="6354458" type="UNKNOWN" weightage="20" keywordseo="US">US</keyword> Department of Health and Human Services (HHS) has secured more than 500,000 treatment courses of the drug for American hospitals through September.</li><li>This represents 100 per cent of Gilead's projected production for July (94,200 treatment courses), 90 per cent of production in August (174,900 treatment courses), and 90 per cent of production in September (232,800 treatment courses), in addition to an allocation for clinical trials.</li></ul> The Donald Trump administration has secured nearly the entire world stock of antiviral drug <keyword id="8775508" type="UNKNOWN" weightage="20" keywordseo="remdesivir">remdesivir</keyword> from US-based Gilead Sciences for the next three months, leaving hardly any stock of the key Covid-19 drug for the rest of the world. As a result of an agreement with the drug maker announced earlier this week, the US Department of Health and Human Services (HHS) has secured more than 500,000 treatment courses of the drug for American hospitals through September. This represents 100 per cent of Gilead's projected production for July (94,200 treatment courses), 90 per cent of production in August (174,900 treatment courses), and 90 per cent of production in September (232,800 treatment courses), in addition to an allocation for clinical trials. A treatment course of remdesivir is, on average, 6.25 vials, the US Health and Human Services said. The agreement allows hospitals in the US to purchase the drug in amounts allocated by HHS and state health departments. Hospitals in the US will receive the product shipped by AmerisourceBergen and will pay no more than Gilead's Wholesale Acquisition Price (WAC), which amounts to approximately $3,200 per treatment course. "President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19," US Health and Human Services Secretary Alex Azar said in a statement. "To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump Administration is doing everything in our power to learn more about life-saving therapeutics for COVID-19 and secure access to these options for the American people." Remdesivir is considered a key drug in the fight against Covid-19 as a randomised clinical trial conducted with the drug on 1,063 patients over 60 centres across US, Europe and Asia demonstrated a faster time to clinical recovery in hospitalised patients as compared to placebo. To expand supply of remdesivir, Gilead earlier announced non-exclusive voluntary licensing agreements with generic pharmaceutical manufacturers based in India, Egypt and Pakistan The agreements allow the companies -- Cipla Ltd.; Dr. Reddy's Laboratories Ltd.; Eva Pharma; Ferozsons Laboratories; Hetero Labs Ltd.; Jubilant Lifesciences; Mylan; Syngene, a Biocon company; and Zydus Cadila Healthcare Ltd. -- to manufacture remdesivir for distribution in 127 countries. The countries consist of nearly all low-income and lower-middle income countries, as well as several upper-middle- and high-income countries that face significant obstacles to healthcare access. The regulatory approval status of remdesivir varies by country, and the distribution of remdesivir within each country is subject to local laws and regulations. Under the licensing agreements, the companies have a right to receive a technology transfer of the Gilead manufacturing process for remdesivir to enable them to scale up production more quickly. The licensees also set their own prices for the generic product they produce. The licenses are royalty-free until the World Health Organization declares the end of the Public Health Emergency of International Concern regarding Covid-19, or until a pharmaceutical product other than remdesivir or a vaccine is approved to treat or prevent Covid-19, whichever is earlier.

US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months

In a world where the corporate landscape has traditionally been male-dominated, Indian women have been making remarkable strides in the business arena. Here, we highlight the achievements of ten influential businesswomen in India who have successfully steered their companies to new heights, breaking through glass ceilings and inspiring the next generation. 1. Zia Mody - Renowned as one of India's leading corporate lawyers, Zia Mody has been the brains behind several high-profile corporate deals. Notably, she orchestrated the successful Airtel and Telenor Group merger and the Schneider Electric acquisition of Larsen &amp; Toubro's electric and automation business. Her firm serves as a trusted advisor to some of India's most successful businesses. 2. Kiran Mazumdar-Shaw Kiran Mazumdar-Shaw, a self-made entrepreneur and one of India's wealthiest women, founded Biocon, a biopharmaceutical company. What began as a venture by accident has now grown into a major player in the pharmaceutical industry, producing a wide range of drugs. 3. Suneeta Reddy's leadership has propelled the Apollo chain of hospitals to unprecedented success. Under her guidance, the company's revenue surged by 14% in FY2018, while Apollo's pharmacy business recorded an 18% growth. Notably, the company also made a significant acquisition by taking over Fortis Healthcare. 4. Alice G. Vaidyan As the Chairman and Managing Director of the General Insurance Corporation of India (GIC), Alice G. Vaidyanathan has achieved remarkable milestones. Under her stewardship, GIC ascended to become one of the top 10 global reinsurers, increasing its market share from 55% to 65%. 5. Mallika Srinivasan, as the Chairman and CEO of Tractors and Farm Equipment (TAFE), transformed her company into the third-largest tractor manufacturer in the world, measured by volume. Her leadership led to diversification of the company's product offerings and remarkable mergers. 6. Zarin Daruwala, who recently held the esteemed position of being the highest-ranking banker in India, took over as the CEO of Standard Chartered Bank in 2016. Within just two years, she steered the bank out of financial turmoil, restoring profitability after a period of declining incomes. 7. Kaku Nakhate Under Kaku Nakhate's guidance, Bank of America Merrill Lynch established a strong presence in India and emerged as a prominent player in the Asia-Pacific region. She played a pivotal role in facilitating several lucrative mergers, such as Infratel and Indus, and Idea Cellular's $1 billion stake in Indus Towers. 8. Shobhana Bhartia has overseen a significant transformation in the editorial segment of HT Media. She played a crucial role in the company's expansion in the Hindi media outlets, effectively doubling its net profit by 213 crores in FY 2017-18. 9. Renuka Ramnath is a trailblazer in the private sector, where she established an independent equity platform managing assets exceeding $1 billion. As the sole board member of EMPEA, a non-profit organization overseeing over $5 trillion in assets across 130 countries, she delivered a fivefold return on investments. 10. Shikha Sharma, a highly respected banker in India, achieved remarkable success as the CEO of Axis Bank. During her leadership from June 2009 to August 2018, the bank's stock prices quadrupled, underscoring her exceptional leadership. These remarkable <keyword id="15506" type="PERSON" weightage="20" keywordseo="Business-women" source="Orion">business women</keyword> serve as inspirational figures, demonstrating that determination, vision, and perseverance can lead to exceptional success in the corporate world. See Also- <a href="https://www.businessinsider.in/entertainment/news/top-10-richest-actresses-of-india/articleshow/72018327.cms">Top 10 Richest Actress in India </a> <a href="https://www.businessinsider.in/business/news/top-10-richest-people-in-the-world/articleshow/74415117.cms">Top 10 richest people in the world</a> <a href="https://www.businessinsider.in/meet-the-top-10-richest-actors-in-india/articleshow/69645149.cms">Top 10 richest actor in India</a>

You Searched For "biocon acquisition" and got 6 results

Biocon Q1FY23 revenue up 23% at Rs 2,217 cr

IANS

Market at record high, Nifty hits 13,000 — Here are the top stock movers in trade today

Navdeep Yadav

Strife At The Top: These 11 C-Suite Execs From India Were ‘Let Go’ In 2013

Sanghamitra Mandal

From SpaceX to Apple, Google and Twitter – here’s how Big Tech is trying to help Ukraine against Russia

Rounak Jain

US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months

IANS

Meet the top 10 business women in India

BI India Bureau

Popular Keywords

Buying Guides